Sapovirus-Associated Diarrhea in Renal Transplant Patient Treated Without Altering Immunosuppression.

IF 0.8 Q4 UROLOGY & NEPHROLOGY
Indian Journal of Nephrology Pub Date : 2025-01-01 Epub Date: 2024-06-29 DOI:10.25259/ijn_507_23
Ravi Andrews, Mohammed Sajid Abdul Samad, Teja Chimtalapudi, Venkat Ramesh, Muna Ather Ali
{"title":"Sapovirus-Associated Diarrhea in Renal Transplant Patient Treated Without Altering Immunosuppression.","authors":"Ravi Andrews, Mohammed Sajid Abdul Samad, Teja Chimtalapudi, Venkat Ramesh, Muna Ather Ali","doi":"10.25259/ijn_507_23","DOIUrl":null,"url":null,"abstract":"<p><p>Solid organ transplant (SOT) recipients are at increased risk of infective diarrheas. In such patients, diarrhea can be complicated by dehydration, leading to acute kidney injury or vascular thrombosis. Viral diarrhea in SOT is reported to be commonly due to cytomegalovirus and norovirus. As sapovirus is not routinely included in diagnostic evaluations, its epidemiology and natural history is not well documented. Anecdotal cases of sapovirus-associated diarrhea in renal transplant recipients have been treated with oral nitazoxanide, often with simultaneous reduction in immunosuppressants. We report sapovirus-associated diarrhea in a renal transplant recipient which responded well within two days to oral nitazoxanide. This, possibly, is the first such report from the Indian subcontinent of adequate control of sapovirus-associated diarrhea without any alteration in the immunosuppressant medications.</p>","PeriodicalId":13359,"journal":{"name":"Indian Journal of Nephrology","volume":"35 1","pages":"101-103"},"PeriodicalIF":0.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763154/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ijn_507_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Solid organ transplant (SOT) recipients are at increased risk of infective diarrheas. In such patients, diarrhea can be complicated by dehydration, leading to acute kidney injury or vascular thrombosis. Viral diarrhea in SOT is reported to be commonly due to cytomegalovirus and norovirus. As sapovirus is not routinely included in diagnostic evaluations, its epidemiology and natural history is not well documented. Anecdotal cases of sapovirus-associated diarrhea in renal transplant recipients have been treated with oral nitazoxanide, often with simultaneous reduction in immunosuppressants. We report sapovirus-associated diarrhea in a renal transplant recipient which responded well within two days to oral nitazoxanide. This, possibly, is the first such report from the Indian subcontinent of adequate control of sapovirus-associated diarrhea without any alteration in the immunosuppressant medications.

在未改变免疫抑制的情况下治疗肾移植患者的腺病毒相关性腹泻。
实体器官移植(SOT)受者患感染性腹泻的风险增加。在这类患者中,腹泻可并发脱水,导致急性肾损伤或血管血栓形成。病毒性腹泻在SOT报道通常是由于巨细胞病毒和诺如病毒。由于萨帕病毒没有常规纳入诊断评估,其流行病学和自然史没有很好的记录。肾移植受者的腺病毒相关性腹泻的轶事病例已经用口服硝唑尼特治疗,通常同时减少免疫抑制剂。我们报告了一个肾移植受者在口服硝唑尼特2天内反应良好的病毒相关腹泻。这可能是印度次大陆第一次在免疫抑制药物没有任何改变的情况下,充分控制了腺病毒相关腹泻的报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Nephrology
Indian Journal of Nephrology UROLOGY & NEPHROLOGY-
CiteScore
1.40
自引率
0.00%
发文量
128
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信